Industry – Page 3

Trump’s Healthcare Nominees Pledge to Divest Industry Investments Amid Controversy

4 months ago talkbio0Tagged Bhattacharya, healthcare appointments, Industry, Jay, Jr., Mehmet, Myasthenic Syndromes, Congenital, NIH, NIH Mouse, ounce, ties, Transplant Registry Unified Management Program

Trump administration, healthcare appointments, NIH, CMS, divestment, industry ties, Jay Bhattacharya, Mehmet Oz, Robert F. Kennedy Jr.

Illumina’s Double-Edged Sword: Navigating US-China Trade Tensions

4 months ago talkbio0Tagged BIOSECURE, China, DNA Sequence, Entity, Illumina, Industry, Tension, TNFRSF19 gene, unreliable

Illumina, China, tariffs, trade tensions, DNA sequencing, unreliable entity list, biotech industry, BIOSECURE Act

Turnstone Biologics Discontinues Final Clinical Program, Initiates Strategic Review Amid Financial Constraints

4 months ago talkbio0Tagged Arenaria, Biological Factors, clinical program, Discontinuation (procedure), Financial cost, Industry, Lymphocytes, Tumor-Infiltrating, Manufacturing, strategic alternatives, TIDAL-01

Turnstone Biologics, TIDAL-01, clinical program discontinuation, layoffs, strategic alternatives, TIL therapy, manufacturing costs, biotech industry challenges

Thermo Fisher Scientific Continues Workforce Reduction with 300 Layoffs in Massachusetts

4 months ago talkbio0Tagged Biotechnology, cost-cutting measures, Industry, Massachusetts (geographic location), Thermo Fisher Scientific, Viral Vector

Thermo Fisher Scientific, layoffs, Massachusetts, viral vector production, workforce reduction, biotechnology industry, cost-cutting measures

Zentalis Pharmaceuticals Cuts Workforce by 40% to Advance WEE1 Inhibitor to Registrational Trial

4 months ago talkbio0Tagged Cancer Therapeutic Procedure, Clinical Trials, Industry, Inhibitor, WEE1, WEE1 gene, Zentalis

Zentalis Pharmaceuticals, layoffs, WEE1 inhibitor, azenosertib, clinical trials, cancer treatment, biotech industry

Sionna and Odyssey Therapeutics Kick Off 2025 Biotech IPO Wave with SEC Filings

5 months ago talkbio0Tagged 2025, File (record), Health care facility, Industry, IPO, JPM, Market, Odyssey, Sionna

Sionna Therapeutics, Odyssey Therapeutics, IPO filings, biotech industry, JPM Healthcare Conference, 2025 IPO market

Key Takeaways from #JPM25: Strategic Partnerships and Acquisitions Dominate the JP Morgan Healthcare Conference

5 months ago talkbio0Tagged Acquisitions, Biopharma, Eli, Eli Lilly, Industry, J.P. Morgan Healthcare, JPM25, partnerships, Pharma, Scorpions, SmithKline Beecham, Zealand

JP Morgan Healthcare Conference, #JPM25, biopharma industry, acquisitions, partnerships, Eli Lilly, Zealand Pharma, GSK, Scorpion Therapeutics

IGM Biosciences Halts Autoimmune Projects Amid Layoffs Following Disappointing Trial Data

5 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, bispecific antibody T cell, engagers, IGM-2644, Immunoglobulin M, imvotamab, Industry

IGM Biosciences, layoffs, autoimmune diseases, bispecific antibody T cell engagers, imvotamab, IGM-2644, biotech industry

Revance Therapeutics Faces Competing Buyout Offers: Teoxane SA Outbids Crown Laboratories

5 months ago talkbio0Tagged Biotechnology, Crown Laboratories, Industry, Revance, sulfanilamide, Teoxane

Revance Therapeutics, Teoxane SA, Crown Laboratories, buyout offers, merger agreement, biotechnology, skincare industry

Javara Undergoes Restructuring, Lays Off Staff Amidst Industry-Wide Challenges

6 months ago talkbio0Tagged Biopharma, Clinical Research, Industry, Javara, restructuring

Javara, layoffs, restructuring, clinical research, biopharma industry challenges